Prof. Parameswaran Venugopal  

 Dr venugopal  Dr. Venugopal is a co-director of the lymphoma program and associate director of hematology and stem cell transplantation at the Rush University Medical Center, Chicago. His clinical expertise includes biologic therapy for cancer, cutaneous T-cell lymphoma, leukemias, acute and chronic lymphoma, myelodysplastic syndrome, myelomas, myeloproliferative disorders, and radioimmunotherapy among others.

Prof. Venugopal has been an invited speaker at many medical institutions, both in the United States and abroad. He has authored or co-authored 91 full-length manuscripts, 7 book chapters, and over 240 abstracts. He also serves on the Advisory Board of the Leukemia Society of America.

_________________________________________________________________________________________

Dr. Edward Libby    

  libby  Dr. Libby is an Associate Professor of medicine at the University of Washington School of Medicine, and a hematologist/oncologist at the Seattle Cancer Care Alliance. His areas of expertise include multiple myeloma, Waldenstrom’s macroglobulinemia, amyloidosis, and indolent lymphomas. His researches focus exclusively on myeloma and lymphoma.

______________________________________________________________________________________

Dr. Binay Shah                       

 binays  Dr. Shah is a hematologist/oncologist and the medical director at the St. Joseph Regional Cancer Center and Blood Institute, Lewiston, Idaho. His clinical research focusses on health services and outcomes. He has published a number of papers in peer-reviewed journals including Journal of Clinical Oncology, British Journal of Hematology, Leukemia and Lymphoma, Acta Oncologica and Annals of Hematology.

Dr. Shah has presented his research papers in national and international conferences. He also chaired the International Conference on Advances in Hematologic Malignancies held in Kathmandu, Nepal, last fall.

Dr. Shah is the Founder and President of the Binaytara Foundation. He serves as a board member of Idaho Society of Clinical Oncology.

_____________________________________________________________________________________

Prof. Divyesh G. Mehta    

dgmehta Dr. Mehta is a Professor of Medicine at University of Arizona College of Medicine and Chief of Hematology Oncology Division at Maricopa Integrated Health System, Phoenix, AZ.

Dr. Mehta has research interests are triple negative breast cancer and multi modality treatment of hepatocellular carcinoma. He has authored 3 book chapters; the most recent is titled Platelet Disorders for the 2003 edition of the API Textbook of Medicine. 

______________________________________________________________________________________

Dr. Luke J Grauke  

grauk Dr. Grauke is a board certified, fellowship trained breast imaging radiologist with Phoenix Radiology and St. Joseph Regional Medical Center. He has contributed to a number of scientific research papers and presentations, particularly within women’s imaging, and has presented at multiple national radiology meetings.

Dr. Grauke maintains a variety of interests within the study of radiology, and is particularly passionate about the early diagnosis and management of patients with breast cancer.

______________________________________________________________________________________

Dr. Sallee Jones 

sallee jones md Dr.  Jones is a general surgeon with St. Joseph Regional Medical Center.  In addition to general surgery, Dr. Jones has a strong passion for treating breast cancer and much of her practice is dedicated to surgical breast oncology.

She graduated from Philadelphia College of Osteopathic Medicine and completed her surgical residency at Midwestern University/Franciscan St James Health in Chicago.  During her training, Dr. Jones spent a portion of her time committed to breast oncology.  Prior to medical school Dr. Jones did her undergraduate training at Georgetown College in Kentucky.  She then completed her PhD in Pharmacology and Physiology at St. Louis University School of Medicine.  She is happy to be a part of a team of physicians dedicated to treating patients with breast cancer.

_____________________________________________________________________________________

Prof. Damiano Rondelli      

rondel  Dr. Rondelli is a Professor of Medicine and Director of Stem Cell Transplant Program at the University of Illinois at Chicago. His clinical research focuses on allogeneic stem cell transplantation. In particular, his interest has been on the use of i.v. busulfan in transplant conditioning regimens; stem cell transplantation in myelofibrosis; and identification of biomarkers of acute and chronic GVHD by flow cytometry. His laboratory focuses on in-vitro and in-vivo models of T cell alloreactivity against hematopoietic stem cells and translational strategies to overcome it.

Dr. Rondelli serves as a member of the International Myeloproliferative Disorders Research Consortium (MPD-RC), funded by an NCI PO1 grant (PI Ronald Hoffman, MD) where he chairs a study using a reduced intensity conditioning regimen in allogeneic stem cell transplantation for patients with myelofibrosis.

Dr. Rondelli has published over 90 full-papers in international peer-reviewed journals including Blood, Leukemia, Biology Blood Marrow Transplantation, and is a co-author of an Italian Hematology textbook. “Lezioni di Ematologia” by Sante Tura et al, Esculapio Bologna, 2003. He is a reviewer of many esteemed journals including Blood, Cancer research, American Journal of Transplantation, etc.

______________________________________________________________________________________

Prof. Renato G Martins  

martins  Dr. Martins, a native of Brazil, is a professor of Medicine at the University of Washington School of Medicine, and Associate Medical Director of Non-Transplant Services and Clinical Research Director of Thoracic/Head and Neck Oncology at the Seattle Cancer Care Alliance.

After completing medical school in Brazil, Dr, Martins came to the United States for further training. He did a fellowship in hematology/oncology at Massachusetts General Hospital and Harvard Medical School while also earning a master’s degree in public health at Harvard in 1998.

Dr. Martins then returned to Brazil, where he was chief of medical oncology at the Brazilian National Cancer Institute in Rio de Janeiro until he accepted his present positions at SCCA and the University of Washington. He arrived in Seattle in February 2004.